Biotech hot picks highlight stocks focused on lung disease, neurological disorders and rare conditions, with growth driven by ...

Looking for top-rated stocks to buy now? Recent analyst updates highlight three companies that have earned Strong Buy ratings ...

Trinity Biotech’s next-generation system is designed to strengthen the company’s position in the global laboratory HbA1c market, which is currently estimated to be worth over $2 billion annually and ...

Analysts might anticipate a good upside ahead for CSL shares, but I think this ASX biotech stock is a much better buy.

Krystal Biotech (NASDAQ: KRYS) has outperformed the market over the past 5 years by 19.89% on an annualized basis producing an average annual return of 32.9%. Currently, Krystal Biotech has a market ...

Fortress Biotech ( ($FBIO) ) has shared an announcement. On December 12, 2025, Fortress Biotech, Inc. amended its Credit Agreement with Oaktree ...

Fortress and its majority-owned subsidiary, Cyprium Therapeutics, said the FDA has accepted an NDA resubmission for CUTX-101, or copper histidinate, a treatment for children who suffer from Menkes ...

Discover top biotech companies for 2026, featuring emerging stars and leaders set for major clinical and regulatory ...

Immutep Limited (NASDAQ:IMMP) is a biotechnology company developing therapies for cancer and autoimmune diseases. The firm’s ...

Ringside’s phase 3 findings reveal the potential varegacestat has to deliver “best-in-class results in a convenient, ...

If you are wondering whether Praxis Precision Medicines is still worth a look after its huge run up, or if the best days are already priced in, you are in the right place to dig into what the market ...

Kodiak Sciences focuses on researching, developing, and commercializing therapeutics for retinal diseases. The stock’s decline reflects typical market reaction to potential dilution from new share ...